日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

FDG-PET/CT 和多模态机器学习模型预测三阴性乳腺癌新辅助化疗后的病理完全缓解

Groheux, David; Ferrer, Loïc; Vargas, Jennifer; Martineau, Antoine; Borgel, Adrien; Teixeira, Luis; Menu, Philippe; Bertheau, Philippe; Gallinato, Olivier; Colin, Thierry; Lehmann-Che, Jacqueline

Role of [(18)F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines

[(18)F]FDG PET/CT 在非特殊类型浸润性乳腺癌患者中的作用:文献回顾及指南比较

Groheux, David; Vaz, Sofia C; Poortmans, Philip; Mann, Ritse M; Ulaner, Gary A; Cook, Gary J R; Hindié, Elif; Pilkington Woll, John Patrick; Jacene, Heather; Rubio, Isabel T; Vrancken Peeters, Marie-Jeanne; Dibble, Elizabeth H; de Geus-Oei, Lioe-Fee; Graff, Stephanie L; Cardoso, Fatima

Joint EANM-SNMMI guideline on the role of 2-[(18)F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)

EANM-SNMMI联合指南:2-[(18)F]FDG PET/CT在非特殊类型乳腺癌中的作用:(获得ACR、ESSO、ESTRO、EUSOBI/ESR和EUSOMA的认可)

Vaz, Sofia C; Woll, John Patrick Pilkington; Cardoso, Fatima; Groheux, David; Cook, Gary J R; Ulaner, Gary A; Jacene, Heather; Rubio, Isabel T; Schoones, Jan W; Peeters, Marie-Jeanne Vrancken; Poortmans, Philip; Mann, Ritse M; Graff, Stephanie L; Dibble, Elizabeth H; de Geus-Oei, Lioe-Fee

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

接受高剂量密集型新辅助化疗的三阴性乳腺癌患者,治疗后间质肿瘤浸润淋巴细胞(TIL)与生存率呈负相关

Giacchetti, Sylvie; Faucheux, Lilith; Gardair, Charlotte; Cuvier, Caroline; de Roquancourt, Anne; Campedel, Luca; Groheux, David; de Bazelaire, Cedric; Lehmann-Che, Jacqueline; Miquel, Catherine; Cahen Doidy, Laurence; Amellou, Malika; Madelaine, Isabelle; Reyal, Fabien; Someil, Laetitia; Hocini, Hamid; Hennequin, Christophe; Teixeira, Luis; Espié, Marc; Chevret, Sylvie; Soumelis, Vassili; Hamy, Anne-Sophie

Breast cancer: initial workup and staging with FDG PET/CT

乳腺癌:FDG PET/CT 的初步检查和分期

Groheux, David; Hindie, Elif

(18)FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients

(18)FDG-PET/CT 和分子标志物预测 HER2 阴性晚期管腔型乳腺癌患者对新辅助化疗的反应和预后

de Cremoux, Patricia; Biard, Lucie; Poirot, Brigitte; Bertheau, Philippe; Teixeira, Luis; Lehmann-Che, Jacqueline; Bouhidel, Fatiha A; Merlet, Pascal; Espié, Marc; Resche-Rigon, Matthieu; Sotiriou, Christos; Groheux, David

(18)FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

(18)FDG-PET/CT在预测ER+/HER2-乳腺癌患者预后中的应用:临床病理参数与PET图像衍生指标(包括肿瘤纹理分析)的比较

Groheux, David; Martineau, Antoine; Teixeira, Luis; Espié, Marc; de Cremoux, Patricia; Bertheau, Philippe; Merlet, Pascal; Lemarignier, Charles

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

临床、组织学或免疫组织化学原发肿瘤特征能否转化为 II/III 期乳腺癌中不同的 (18)F-FDG PET/CT 体积和异质性特征?

Groheux, David; Majdoub, Mohamed; Tixier, Florent; Le Rest, Catherine Cheze; Martineau, Antoine; Merlet, Pascal; Espié, Marc; de Roquancourt, Anne; Hindié, Elif; Hatt, Mathieu; Visvikis, Dimitris